Answers are grounded in this paper and cite their sources.
KEYWORDS: cardiovascular diseasesecondary preventionantiplatelet agentsaspirinP2Y12 receptor antagonists
No takes yet. Share an insight, caveat, or question.
Carlin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: